ResearcherShanghai Jiao Tong UniversityNo recent work listed
Yuchen Ji
Matched on ORCID iD 0000-0002-0730-9970; OpenAlex author ID A5088256899. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2023: 5 papers
Papers 5
- Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A retrospective… Co-author DOI 10.1002/cam4.5543↗
- Health-related quality of life and survival outcomes for patients with major depressive disorder and anxiety: A longitudinal study in pancreatic ductal adenoca… Co-author DOI 10.1002/cam4.6577↗
- A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis. Co-author DOI 10.1007/s13402-023-00818-5↗
- TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12967-023-04742-y↗
- The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. Co-author DOI 10.1245/s10434-022-12700-z↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yiran Zhou · 4 shared papers, 2023 · strength 0.74
- Paper Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreati… DOI 10.1002/cam4.5543↗
- Paper Health-related quality of life and survival outcomes for patients with major depressive disorder and anxiety: A longitu… DOI 10.1002/cam4.6577↗
- Paper The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. DOI 10.1245/s10434-022-12700-z↗
- Baiyong Shen · 4 shared papers, 2023 · strength 0.74
- Paper Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreati… DOI 10.1002/cam4.5543↗
- Paper Health-related quality of life and survival outcomes for patients with major depressive disorder and anxiety: A longitu… DOI 10.1002/cam4.6577↗
- Paper The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. DOI 10.1245/s10434-022-12700-z↗
- Haoda Chen · 3 shared papers, 2023 · strength 0.57
- Paper Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreati… DOI 10.1002/cam4.5543↗
- Paper Health-related quality of life and survival outcomes for patients with major depressive disorder and anxiety: A longitu… DOI 10.1002/cam4.6577↗
- Paper The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. DOI 10.1245/s10434-022-12700-z↗
- Xiaxing Deng · 3 shared papers, 2023 · strength 0.54
- Paper Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreati… DOI 10.1002/cam4.5543↗
- Paper The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. DOI 10.1245/s10434-022-12700-z↗
- Paper TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarci… DOI 10.1186/s12967-023-04742-y↗
- Ziyun Shen · 2 shared papers, 2023 · strength 0.38
- Paper Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreati… DOI 10.1002/cam4.5543↗
- Paper The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. DOI 10.1245/s10434-022-12700-z↗
- Weishen Wang · 2 shared papers, 2023 · strength 0.38
- Paper A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis. DOI 10.1007/s13402-023-00818-5↗
- Paper The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. DOI 10.1245/s10434-022-12700-z↗
- Jiewei Lin · 1 shared paper, 2023 · strength 0.20
- Shulin Zhao · 1 shared paper, 2023 · strength 0.20
- Da Fu · 1 shared paper, 2023 · strength 0.20
- Jingwei Li · 1 shared paper, 2023 · strength 0.20
- Baiyong Shen · 1 shared paper, 2023 · strength 0.20
- Hongzhe Li · 1 shared paper, 2023 · strength 0.19
- Chenghong Peng · 1 shared paper, 2023 · strength 0.17
- Yuanchi Weng · 1 shared paper, 2023 · strength 0.17
- Jun Zhang · 1 shared paper, 2023 · strength 0.17
- Yu Jiang · 1 shared paper, 2023 · strength 0.17
- Ningzhen Fu · 1 shared paper, 2023 · strength 0.17
- Jun Wang · 1 shared paper, 2023 · strength 0.17
- Dongfeng Cheng · 1 shared paper, 2023 · strength 0.17
- Kai Qin · 1 shared paper, 2023 · strength 0.17
- Jiabin Jin · 1 shared paper, 2023 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.